Global Cardiovascular Clinical Trials Market Size To Exceed USD 9.76 Billion By 2033 l a CAGR of 6.18%
June 11, 2024 02:00 ET
|
SPHERICAL INSIGHTS LLP
New York, United States , June 11, 2024 (GLOBE NEWSWIRE) -- The Global Cardiovascular Clinical Trials Market Size is to Grow from USD 5.36 Billion in 2023 to USD 9.76 Billion by 2033, at a CAGR of...
Cell Culture Market Is Expected To Reach A Revenue Of USD 80.3 Bn By 2033, At 11.0% CAGR: Dimension Market Research
June 10, 2024 10:53 ET
|
Dimension Market Research
New York, June 10, 2024 (GLOBE NEWSWIRE) -- Market Overview The Global Cell Culture Market size is expected to reach USD 31.4 billion by 2024 and is further anticipated to reach USD 80.3 billion...
MoonLake Immunotherapeutics Announces Positive Regulatory Feedback from both FDA and EMA on Path for the Phase 3 Program for the Nanobody® sonelokimab in Psoriatic Arthritis
June 10, 2024 08:00 ET
|
MoonLake Immunotherapeutics AG
MoonLake Immunotherapeutics Announces Positive Regulatory Feedback from both FDA and EMA on Path for the Phase 3 Program for the Nanobody® sonelokimab in Psoriatic Arthritis Builds upon the positive...
Nasdaq Determines That TransCode Therapeutics Has Regained Compliance with Continued Listing Requirements
June 10, 2024 07:00 ET
|
TransCode Therapeutics, Inc.
Nasdaq Determines That TransCode Therapeutics Has Regained Compliance with Continued Listing Requirements
Macomics Announces Appointment of Simon Dew as New Chief Business Officer
June 10, 2024 04:00 ET
|
Macomics Limited
Macomics continues to expand its leadership team to accelerate the development of first-in-class macrophage-targeted therapiesSimon Dew brings over 25 years of experience in pharmaceutical business...
Seniors in Metro Vancouver Invited to Participate in a Clinical Trial Assessing a New Immunomodulator Designed to Restore Immune Function in the Elderly
June 07, 2024 20:18 ET
|
Qu Biologics, Inc.
Vancouver, BC, June 07, 2024 (GLOBE NEWSWIRE) -- Qu Biologics Inc., a Burnaby-based clinical-stage biotechnology company, is pleased to announce that the RESILIENCE Study, a clinical trial...
Barinthus Bio's VTP-300 Trials Demonstrate Ability to Achieve Undetectable HBsAg levels and Statistical Significance in Lowering HBsAg Levels in People with Chronic Hepatitis B
June 06, 2024 11:15 ET
|
Barinthus Biotherapeutics
Barinthus Bio presents updated data from two clinical trials in people with chronic hepatitis B at EASL Congress 2024.
BioNTX Announces 10th Annual iC³® Life Science & Healthcare Innovation Summit
June 06, 2024 10:00 ET
|
Bio North Texas
BioNTX, the leading biotechnology trade organization in North Texas, is thrilled to announce the 10th Annual iC³® Life Science Summit.
Qu Biologics and Foundation Medicine Collaborate to Impact the Care of Patients with Late-Stage Colorectal Cancer
June 06, 2024 08:00 ET
|
Qu Biologics, Inc.
BURNABY, British Columbia, June 06, 2024 (GLOBE NEWSWIRE) -- Qu Biologics Inc., a clinical stage biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a novel platform of...
Global Metabolomics Report 2024: Market Poised for Substantial Growth, Expected to Reach $6.5 Billion by 2032, Fueled by Advancements in Personalized Medicine and Chronic Disease Prevalence
June 06, 2024 04:06 ET
|
Research and Markets
Dublin, June 06, 2024 (GLOBE NEWSWIRE) -- The "Global Metabolomics Market Report by Product, Indication, Application, and Region 2024-2032" report has been added to ResearchAndMarkets.com's...